Qiagen (QGEN)
40.57
+0.04 (0.10%)
Upcoming Events
Latest Headlines
QIAGEN touts Cyclospora detection tools amid U.S. outbreak
July 15, 2026 4:05 PM - StreetInsider
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
July 15, 2026 4:05 PM - BizWire
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
July 15, 2026 8:48 AM - BizWire
Qiagen launches new bloodstream infection panel in Europe
July 14, 2026 4:07 PM - StreetInsider
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
July 14, 2026 4:05 PM - BizWire
Berenberg Downgrades QIAGEN NV (QIA:GR) (QGEN) to Hold
July 14, 2026 3:47 AM - StreetInsider
Berenberg Downgrades Qiagen NV (QGEN) to Hold
July 14, 2026 3:39 AM - StreetInsider
Qiagen NV (QGEN) PT Raised to $47 at Baird
July 13, 2026 7:18 AM - StreetInsider
Some Qiagen Suitors Are Said To Mull Offering At Least $50/Shr - Bloomberg
July 9, 2026 10:34 AM - StreetInsider
Qiagen (QGEN) 2700 contracts of July 40 calls trade, share price up 11%
July 9, 2026 10:21 AM - StreetInsider
Qiagen Is Said To Draw Takeover Interest From Eqt, Advent - Bloomberg
July 9, 2026 10:12 AM - StreetInsider
Kepler Cheuvreux Starts QIAGEN NV (QIA:GR) (QGEN) at Hold
June 25, 2026 3:38 AM - StreetInsider
Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
June 23, 2026 3:57 AM - StreetInsider
Qiagen NV (QGEN) Reiterated at Hold by Stifel Post QIAcuity digital PCR Deep-Dive
June 16, 2026 7:24 AM - StreetInsider
QIAGEN expands QIAcuity digital PCR portfolio with gene expression tools
June 15, 2026 2:58 AM - StreetInsider
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
June 15, 2026 1:30 AM - BizWire
TD Cowen notes short interest shifts in life science tools stocks
June 10, 2026 10:50 AM - StreetInsider
Form SCHEDULE 13G/A QIAGEN N.V. Filed by: MASSACHUSETTS FINANCIAL SERVICES CO /MA/
June 5, 2026 3:16 PM - SEC Filing
Form SD QIAGEN N.V.
June 1, 2026 6:01 AM - SEC Filing
QIAGEN releases digital PCR assays for Bundibugyo ebolavirus research
May 28, 2026 4:06 PM - StreetInsider
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 28, 2026 4:05 PM - BizWire
QIAGEN launches AI assistant for laboratory workflow support
May 20, 2026 4:07 PM - StreetInsider
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 20, 2026 4:05 PM - BizWire
QIAGEN partners with NVIDIA to integrate AI into drug discovery platform
May 19, 2026 4:05 PM - StreetInsider
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 19, 2026 4:05 PM - BizWire
Qiagen NV (QGEN) PT Lowered to $36 at Stifel on 'Lower Growth Outlook'
May 18, 2026 7:40 AM - StreetInsider
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026 2:00 AM - BizWire
Form 6-K QIAGEN N.V. For: Mar 31
May 8, 2026 6:06 AM - SEC Filing
Form 6-K QIAGEN N.V. For: Mar 31
May 8, 2026 6:06 AM - SEC Filing
Qiagen NV (QGEN) PT Lowered to $40 at TD Cowen
May 7, 2026 8:53 AM - StreetInsider
QIAGEN plans automated tuberculosis testing workflow for late 2027
May 7, 2026 6:01 AM - StreetInsider
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 7, 2026 6:00 AM - BizWire
Qiagen (QGEN) Reports In-Line Q1 EPS
May 7, 2026 1:58 AM - StreetInsider
QIAGEN Reports Full Results for Q1 2026
May 6, 2026 4:05 PM - BizWire
Form 6-K QIAGEN N.V. For: Mar 31
May 1, 2026 9:49 AM - SEC Filing
Qiagen NV (QGEN) PT Lowered to $45 at JPMorgan
April 29, 2026 9:01 AM - StreetInsider
QIAGEN NV (QIA:GR) (QGEN) PT Lowered to EUR34 at Morgan Stanley
April 29, 2026 4:31 AM - StreetInsider
Baird Upgrades Qiagen NV (QGEN) to Outperform
April 29, 2026 2:45 AM - StreetInsider
Qiagen NV (QGEN) PT Lowered to $38 at Barclays
April 28, 2026 4:07 PM - StreetInsider
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
April 27, 2026 4:16 PM - StreetInsider
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026 4:16 PM - BizWire
Full Article List
